Summary:
This is a Phase 1/2 observer-blind, multicenter, randomized, active-controlled, dose-selection study. The study will evaluate the safety, tolerability, immunogenicity, and persistence of immunity of a VZV modRNA vaccine against VZV (shingles) in healthy individuals 50 through 69 years of age.
The George Washington University is seeking volunteers for a shingles vaccine clinical trail who are:
- Between the ages 50-69, healthy, and living in the DC metro area
- Have never had shingles or received a shingles vaccine
Qualified Participants May Receive:
Participants will possibly receive a licensed VZV (Shingles) vaccine at no cost and contribute to research.